Notification of Final Results 30 April 2012 (6273B)
2012年4月19日 - 3:01PM
RNSを含む英国規制内ニュース (英語)
TIDMATD
RNS Number : 6273B
Asterand PLC
19 April 2012
19 April 2012
ASTERAND PLC
('Asterand' or 'the Company')
Notification of Final Results
Date: Monday 30 April 2012
Asterand plc ("Asterand" or the "Group" - LSE: ATD), a leading
supplier of human tissue based solutions to pharmaceutical and
biotechnology companies engaged in drug discovery research will
announce its Final Results for the year ended 31 December 2011, on
Monday 30 April 2012.
- Ends -
Contacts:
Asterand plc
Jack Davis, Chairman and Interim Chief Tel: + 44 (0) 1763 211 600 /
Executive Officer + 1 (313) 263-0960
Alan Fishman, Interim Chief Financial As above
Officer
Daniel Stewart & Company plc
Antony Legge Tel: +44 (0) 20 7776 6566
About Asterand
Asterand plc is a leading supplier of high quality human tissue
and tissue-based services. Our comprehensive approach to human
tissue and research services offers pharmaceutical, biotech and
diagnostic companies the unique opportunity to have one company
meet all of their human biomaterial needs along the continuum of
drug discovery and development. Our mission is to accelerate target
discovery and compound validation and enable pharmaceutical and
biotechnology companies to take safer and more effective drugs into
the market. For more information, go to www.asterand.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORQVLFFLZFLBBD
Bioseek (LSE:ATD)
過去 株価チャート
から 5 2024 まで 6 2024
Bioseek (LSE:ATD)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Bioseek (ロンドン証券取引所): 0 recent articles
その他のAsterandニュース記事